| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.77B | 20.52B | 19.54B | 19.01B | 17.77B | 7.61B |
| Gross Profit | 12.46B | 3.64B | 5.59B | 5.96B | 3.03B | -198.60M |
| EBITDA | 3.92B | 4.82B | 5.71B | 5.57B | 5.17B | 1.42B |
| Net Income | 3.39B | 1.18B | 2.78B | 2.67B | 2.16B | -962.00M |
Balance Sheet | ||||||
| Total Assets | 43.09B | 44.03B | 43.09B | 44.26B | 50.19B | 49.72B |
| Cash, Cash Equivalents and Short-Term Investments | 8.78B | 10.22B | 8.78B | 11.79B | 16.73B | 14.17B |
| Total Debt | 12.91B | 10.64B | 12.91B | 13.45B | 15.34B | 15.92B |
| Total Liabilities | 27.02B | 26.34B | 27.02B | 27.52B | 29.94B | 26.92B |
| Stockholders Equity | 15.66B | 17.26B | 15.66B | 16.34B | 19.86B | 22.41B |
Cash Flow | ||||||
| Free Cash Flow | 2.94B | 2.59B | 2.83B | 3.81B | 7.47B | -289.20M |
| Operating Cash Flow | 4.71B | 5.22B | 4.71B | 5.05B | 9.15B | 2.83B |
| Investing Cash Flow | -3.30B | -2.76B | -3.30B | -1.44B | -490.10M | -2.32B |
| Financing Cash Flow | -4.33B | -2.65B | -4.33B | -8.78B | -5.88B | 5.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | S$2.77B | 6.45 | 8.83% | 5.55% | 13.00% | 9.36% | |
66 Neutral | S$3.54B | 21.47 | 6.65% | 2.68% | 14.28% | 21.19% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | S$20.20B | 17.20 | 11.35% | 6.21% | 5.03% | -59.42% | |
62 Neutral | S$4.83B | 16.71 | 10.43% | 1.44% | 10.26% | 30.63% | |
59 Neutral | S$32.32B | 109.64 | 17.50% | 2.01% | 9.50% | -34.09% |